Unique Targeted Genetic Tests

T e c h n o l o g y

Chronic diseases cost the U.S. $3.8 trillion each year. To the individual and families impacted by serious chronic conditions, the cost in terms of quality of life and shortened life expectancy is incalculable.

What if we could manage chronic diseases not only for individual patients, but for their children, grandchildren and generations to come? Tesis Labs has made that vision a reality.

Tesis Labs uses a genetically integrated medical platform to revolutionize chronic disease management through groundbreaking approaches to targeted genetic sequencing and comprehensive genetic data collection.

We create a unique targeted next-generation sequencing (NGS) panels empowering clinicians to identify changes in chromosomes, genes or proteins. These NGS panels are the cornerstone for predictive outcomes regarding the top five chronic health conditions in the U.S. – heart disease, cancer, lung disease, Alzheimer’s disease and diabetes.

Automation and optimization enable Tesis Labs to achieve high throughput while retaining customization. Tesis Labs’ cancer detection technology and processes are the most advanced in the industry. Our 10-color flow cytometry system allows a comprehensive view of blood samples, bone marrow and tissue. Additional testing can be done on site. These insights provide genetic data for patients of all ages to help guide medical treatment and preventative care.

The Tesis Labs’ mission is to provide the missing link needed to transform medicine. We’re doing this by helping the people who are changing the world by putting patients at the center of care.

Targeted Genetic